Close Menu

NEW YORK – Natera said on Thursday after the close of the market that its third quarter revenues grew 26 percent year over year, driven by an overall increase in testing volumes, particularly in reproductive health.

Revenues for the three months ended Sept. 30 totaled $98.1 million, up from $77.9 million a year ago and besting the average Wall Street estimate of $87.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.